Pharmaceutical preparations, namely, immunosuppressants, pharmaceutical preparations for the treatment of COVID-19, and anti-interleukin-6 (il-6) receptor monoclonal antibody for the treatment of disease caused by il-6 production; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for suppressing cytokine; pharmaceutical preparations for the treatment of arteritis; pharmaceutical preparations for the treatment of lung diseases; pharmaceutical preparations for immunity adjustment; monoclonal antibodies for medical purposes; pharmaceutical preparations for the treatment of auto-immune diseases
Pharmaceuticals